PTC 治疗公司和囊状纤维化基金会支持本研究。
PTC Therapeutics and Cystic Fibrosis Foundation Therapeutics supported this study.
评估囊状纤维化患者以静脉注射施予抗生素时，完全内植式静脉输注装置是否能提供一安全和有效的路径。
To assess if totally implantable venous access devices provide a safe and effective route for venous access for intermittent administration of intravenous antibiotics in people with cystic fibrosis.
完全内植式静脉输注装置被广泛用于囊状纤维化之病人，以便在患者进行药物滴注时给予间歇性的静脉输注。
Totally implantable vascular access devices are widely used in people with cystic fibrosis to provide intermittent venous access for therapeutic infusions.
应用推荐